| Literature DB >> 30958799 |
Ting Wen1, Bruce J Aronow2, Yrina Rochman1, Mark Rochman1, Kiran Kc1, Phil J Dexheimer2, Philip Putnam3, Vincent Mukkada3, Heather Foote1, Kira Rehn1, Sam Darko4, Daniel Douek4, Marc E Rothenberg1.
Abstract
T cell heterogeneity is highly relevant to allergic disorders. We resolved the heterogeneity of human tissue CD3+ T cells during allergic inflammation, focusing on a tissue-specific allergic disease, eosinophilic esophagitis (EoE). We investigated 1088 single T cells derived from patients with a spectrum of disease activity. Eight disparate tissue T cell subtypes (designated T1-T8) were identified, with T7 and T8 enriched in the diseased tissue. The phenotypes of T7 and T8 resemble putative Treg (FOXP3+) and effector Th2-like (GATA3+) cells, respectively. Prodigious levels of IL-5 and IL-13 were confined to HPGDS+ CRTH2+IL-17RB+FFAR3+CD4+ T8 effector Th2 cells. EoE severity closely paralleled a lipid/fatty acid-induced activation node highlighted by the expression of the short-chain fatty acid receptor FFAR3. Ligands for FFAR3 induced Th2 cytokine production from human and murine T cells, including in an in vivo allergy model. Therefore, we elucidated the defining characteristics of tissue-residing CD3+ T cells in EoE, a specific enrichment of CD4+ Treg and effector Th2 cells, confinement of type 2 cytokine production to the CD4+ effector population, a highly likely role for FFAR3 in amplifying local Th2 responses in EoE, and a resource to further dissect tissue lymphocytes and allergic responses.Entities:
Keywords: Allergy; Immunology
Mesh:
Substances:
Year: 2019 PMID: 30958799 PMCID: PMC6486341 DOI: 10.1172/JCI125917
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808